Among these identified inhibitors, Disulfiram and Carmofur are FDA-approved drugs, whereas Ebselen, Tideglusib, Shikonin, TDZD-8 and PX-12 are undergoing currently in preclinical studies (Fig. 7). Besides, Ebselen also possessed effective anti-viral activity in cell-based assays. This interesting ...